Lonza has announced an expansion of its service offering for orally delivered biologic therapies to support the unique development and manufacturing needs of smart capsules companies.
Koki Obara, marketing manager, Asahi Kasei Medical, delves into the current biopharmaceutical environment, the critical role of virus removal filters, and how Planova FG1 stands to impact the development and production of biopharmaceuticals.
After hearing the news of Cytiva and Syvento Bitotech's new facility, European Pharmaceutical Manufacturer followed up with Ludovic Brellier, president of Hardware Solutions at Cytiva, for more information.
SyVento Biotech has opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7 000 m2, including lab and production areas, offices, and shared spaces.
Lonza announced the completion of the first GMP product batch supported from the recently completed next-generation mammalian manufacturing facility in Portsmouth (US).
Pheast Therapeutics announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage "don't eat me" signal on cancer cells.
AstraZeneca’s drug Fasenra (benralizumab) has been approved in the European Union as an additional treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA).
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex equipment, essential products and expert training to foster innovations in biopharma manufacturing.
